A clinical trial led by the University of Minnesota on a post-exposure treatment for the coronavirus (COVID-19) is expanding participant enrollment opportunities.
University of Minnesota Medical School researcher, Aaron Kelly, PhD, authored a study on a new pediatric obesity medication with the potential to help adolescents with obesity better manage their weight.
The Division of Movement Disorders in the Department of Neurology was recently named a “Center of Care” by the CurePSP Foundation.
Susan Everson-Rose, PhD, MPH, and Anne Blaes, MD, will conduct a pilot study this spring to discover how mind-body interventions could help prevent cardiovascular disease for women with breast cancer.
The University of Minnesota today is launching a clinical trial on a post-exposure treatment for coronavirus COVID-19 disease.
The team hopes it will accelerate biomedical research and offer a new protocol for studying the vulnerability of the model and a new cardiovascular phenotype.
Bone loss resulting from spaceflight, bedrest or metabolic osteoporosis can result in catastrophic skeletal morbidities. The OsteoOmics Project was designed to examine bone cells under various gravitational forces in order to help scientists work to create better treatments for patients with bone loss on Earth.
A team of researchers at the University of Minnesota Medical School recently proved the ability to grow human-derived blood vessels in a pig—a novel approach that has the potential for providing unlimited human vessels for transplant purposes.
Marco Pravetoni, PhD, has been awarded five multi-million dollar grants from the National Institutes of Health to develop novel medical interventions against opioid use disorders and overdose and initiate clinical testing.
Michelle Biros, MD, MS, FACEP, and team perform and consult on the FDA’s exception from informed consent clinical trials that enroll patients during life-threatening situations.